2m 2m 2m 2m 2m 2m 2m
EDGEWISE THERAP (EWTX)
NASDAQ
$47.52+$0.99 (+2.13%)
Price as of Nov 11, 2026 7:30 PM EST- $5.1BMarket Cap
- 116.62%1-Year Change
- BiotechnologyIndustry
EDGEWISE THERAP (EWTX)
$47.52+$0.99 (+2.13%)
EWTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $46.53 | ||
Change | -$2.21 (-4.53%) | ||
Open | $46.82 | ||
High | $47.79 | ||
Low | $44.79 | ||
Previous Close | $48.74 | ||
Volume | 1,939,842 | ||
30-Day Average Volume | 1,748,418 | ||
1-Week Change | 23.49% | ||
1-Month Change | 19.12% | ||
1-Year Change | 116.62% | ||
3-Year Change | 744.46% | ||
5-Year Change | 134.17% | ||
Fundamentals | |||
Shares Outstanding | 109.5M | ||
Total Assets | $1.8B | ||
Market Cap | $5.1B | ||
Enterprise Value | $5.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | $1.2B | ||
Free Cash Flow | -$78.3M | ||
EBIT | $1.3B | ||
EBITDA | $1.3B | ||
Net Working Capital | $1.6B | ||
EPS | $9.65 | ||
Enterprise Value/EBITDA | 4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | 5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -65 | ||
Price/Operating Cash Flow | -65 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue